ข่าวประชาสัมพันธ์ Cardiovascular Disease+Secretariat

Photo Release: KTC members make donation for children with congenital heart defect.

Mr. Dusit Ratchatasetanant(right), Executive Vice President Human Resources, “KTC” or Krungthai Card Public Company Limited, presented 80,441.50 Baht donation collected through the boxes at KTC Touch customer service centers to Dr. Peerapat Makarapong (left), Board Member and Secretariat, Pediatric Cardiac Surgery Foundation Institute of Cardiovascular Disease, Rajvithi Hospital, to help fund the lifesaving surgeries required by affected children of poor financial status. KTC has been

The 2024 East Asian Seas Congress and World Ocean Week in Xiamen Held

Secretariat of World Ocean Week in Xiamen The 2024 East Asian Seas Congress (EASC) and World Ocean Week in Xiamen began in Xiamen, east China's Fujian, on November 6th. The event was hosted by the Partnerships in Environmental...

4.5 million: Civil 20 India reached out to the highest number of people in C20's history

The Civil 20 (C20) Policy Pack urges the G20 Heads of State to put aside self-interests and address the deep inequalities that have increased after the pandemic. The Civil 20, an official Engagement Group of...

Fukuoka City Announces Fukuoka Prize 2023 Laureates

Fukuoka City (Secretariat of Fukuoka Prize Committee) on May 19 announced the laureates for the Fukuoka Prize 2023. The Grand Prize has been awarded to Professor Thongchai WINICHAKUL, a Thai historian who made a significant influence globally with...

Neuome Peptides Pte. Ltd., a Singapore-ba... Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia — Neuome Peptides Pte. Ltd., a Singapore-based company has established an a...

ศ.(วิจัย) ดร.ชุติมา เอี่ยมโชติชวลิต ผู้ว่... วว. ร่วมการประชุม WAITRO General Assembly 2022 ณ เมืองเคปทาวน์ แอฟริกาใต้ — ศ.(วิจัย) ดร.ชุติมา เอี่ยมโชติชวลิต ผู้ว่าการสถาบันวิจัยวิทยาศาสตร์และเทคโนโลย...

Fukuoka Prize 2021 Award Ceremony Held Online for First Time in Its History; Arts and Culture Prize Awarded to Mr. Prabda YOON of Thailand

Fukuoka City (Secretariat of Fukuoka Prize Committee) announced on October 1 that the City and the Fukuoka City International Foundation held an award ceremony...

ญี่ปุ่นเตรียมจัดการประชุม "Innovation for Cool Earth Forum (ICEF2021)" ออนไลน์ หวังเร่งความเป็นกลางทางคาร์บอน

ICEF Secretariat ประกาศในวันที่ 17 กันยายนว่า กระทรวงเศรษฐกิจ การค้า และอุตสาหกรรม (METI) ของญี่ปุ่น และองค์การพัฒนาเทคโนโลยีพลังงานใหม่และอุตสาหกรรม (NEDO) เตรียมเป็นเจ้าภาพการประชุม ...

หน่วยงานการศึกษานิวซีแลนด์ (Education New... สัมมนาออนไลน์ ฟรี "เทคโนโลยีการศึกษาและความปลอดภัยทางดิจิทัล" — หน่วยงานการศึกษานิวซีแลนด์ (Education New Zealand; ENZ) ร่วมกับ สำนักงานเลขาธิการองค์การรั...

Accelerating Carbon Neutrality "Innovation for Cool Earth Forum (ICEF2021) -Online-"

The ICEF Secretariat announced on September 17 that Japan's Ministry of Economy, Trade and Industry (METI) and New Energy and Industrial Technology Development Organization (NEDO) will host "Innovation for Cool Earth...

โรคเบาหวานเสี่ยงโรคหลอดเลือดหัวใจ (Cardio... เบาหวานเสี่ยงต่อโรคหัวใจอย่างไร — โรคเบาหวานเสี่ยงโรคหลอดเลือดหัวใจ (Cardiovascular Disease and Diabetes) ร้อยละ 68 ของผู้ป่วยเบาหวาน อายุ 65 ปีขึ้นไปจะ...

International Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Have Cardiovascular Disease Risk Factors and/or Have Experienced a Cardiovascular Event

- Cardiovascular disease (CVD) is the leading cause of disability and death in people with type 2 diabetes[1] -...

World Heart Day: Nearly One in Five Deaths From Cardiovascular Disease are Caused by Air Pollution, a Total of 3 Million Deaths Globally Every Year

- On World Heart Day (WHD), 29 September 2018, World Heart Federation (WHF) is raising awareness of the link between poor air quality and cardiovascular...

IDF and Novo Nordisk Launch First-ever Global Survey on Cardiovascular Disease Awareness among People with Type 2 Diabetes

- Taking Diabetes to Heart is a global online survey for people with type 2 diabetes to gain important insights about their awareness of cardiovascular disease (CVD) Globally,...

Resverlogix Completes Dosing In ASSURE Clinical Trial

IVUS data will evaluate plaque regression in patients with high-risk Cardiovascular Disease TSX Exchange Symbol: RVX Resverlogix Corp. (TSX:RVX) today announced that it has completed dosing in ASSURE, a Phase 2b clinical trial evaluating RVX-208,...

Resverlogix's BET Protein Inhibitor RVX-208 Meets Primary Endpoint in SUSTAIN Clinical Trial in Patients With High Risk Cardiovascular Disease

Significant Increase in Functional HDL Persisted Throughout the 24-week Study Period Results from ASSURE Study Expected H1 2013, Using IVUS to Measure...

ASIANET: Worldwide Study to Evaluate New Approach

Worldwide Study to Evaluate New Approach to Preventing Cardiovascular Disease in Ace Inhibitor-Intolerant Patients - Largest Cardiovascular Protection Trial Ever Conducted in This Patient Population Will Parallel Landmark 'ONTARGET' Study - MILAN,...

ASIANET: Landmark Worldwide 'ONTARGET' Study of Approximately 28,000 Patients

Landmark Worldwide 'ONTARGET' Study of Approximately 28,000 Patients to Evaluate the Role of a New Therapeutic Approach In Prevention Of Cardiovascular Disease Study at Up to 700 Sites Will Build On Landmark Hope Trial...